CMT 170 Cell Line
Invented at Cancer Research UK London Research Institute: Lincoln's Inn Fields
- Datasheet
- References (2)
- Inventor Info
Info
| Catalogue Number | 153332 |
| Host | Mouse |
| Tissue | Lung |
| Disease Keywords | Lung carcinoma, metastatic |
| Model | Tumour line |
| Relevance | The tumourigenic and metastatic CMT 170 murine cell line is sub-line of CMT 64 and an in vivo mouse tumourigenesis system to study the growth characteristics and metastasis of mouse tumour lines. it demonstrates stable growth characteristics and morphology in culture and in lung metastasis induced after subcutaneous inoculation of mice. CMT 170 was selected as a sub-line of CMT 64 for its increased metastatic ability. |
| Production Details | Mouse; CMT-170 isolated from primary alveogenic lung carcinoma tumour mass in C57BL/lcrf mouse, achieving stable morphology and growth rate in culture, similar to growth rate and morphology in primary tumour, and in lung metastasis induced after subcutaneous innoculation of mice. |
| Research Area | Cancer |
| Growth/Phenotype Keywords | Tumorigenesis |
| Recommended Growing Conditions | DMEM with 10% FCS, supplemented with 20mM Hepes. |
| Cellosaurus ID | CVCL_B492 |
References: 2 entries
Franks et al. 1984. Br J Cancer. 49(4):423-9. PMID: 6324837.
Ultrastructural tumour differentiation and organ specificity in high and low metastatic lines from a mouse lung carcinoma.
Europe PMC ID: 6324837
Add a reference
References: 2 entries
Franks et al. 1984. Br J Cancer. 49(4):423-9. PMID: 6324837.
Ultrastructural tumour differentiation and organ specificity in high and low metastatic lines from a mouse lung carcinoma.
Add a reference
